Business Description
VitaSpring Biomedical Co Ltd
NAICS : 325411
SIC : 2833
Description
VitaSpring Biomedical Co Ltd is a start-up business company. The company's objective is to develop new drugs in cell medicine. The company also plans to produce X.MSC cytopharmaceuticals.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.07 | |||||
| Equity-to-Asset | 0.69 | |||||
| Debt-to-Equity | 0.2 | |||||
| Debt-to-EBITDA | 0.28 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 2606.7 | |||||
| Beneish M-Score | 0.39 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 100 | |||||
| 9-Day RSI | 99.78 | |||||
| 14-Day RSI | 97.77 | |||||
| 6-1 Month Momentum % | 5.26 | |||||
| 12-1 Month Momentum % | 60 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.32 | |||||
| Quick Ratio | 4.32 | |||||
| Cash Ratio | 0.05 | |||||
| Days Sales Outstanding | 168.83 | |||||
| Days Payable | 155.22 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -55.9 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 40.87 | |||||
| Operating Margin % | 23.66 | |||||
| Net Margin % | 18.8 | |||||
| ROE % | 62.61 | |||||
| ROA % | 37.52 | |||||
| ROIC % | 50.97 | |||||
| ROC (Joel Greenblatt) % | 65.2 | |||||
| ROCE % | 63.46 | |||||
| Years of Profitability over Past 10-Year | 2 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 4000 | |||||
| PE Ratio without NRI | 4000 | |||||
| PS Ratio | 666.67 | |||||
| PB Ratio | 2000 | |||||
| Price-to-Tangible-Book | 1600 | |||||
| EV-to-EBIT | 2805.29 | |||||
| EV-to-EBITDA | 2772.34 | |||||
| EV-to-Revenue | 663.71 | |||||
| EV-to-FCF | -13712.14 | |||||
| Price-to-Graham-Number | 533.33 | |||||
| Price-to-Net-Current-Asset-Value | 1600 | |||||
| Earnings Yield (Greenblatt) % | 0.04 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:VSBC
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
VitaSpring Biomedical Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 4.979 | ||
| EPS (TTM) ($) | 0.004 | ||
| Beta | 0.23 | ||
| Volatility % | 13.15 | ||
| 14-Day RSI | 97.77 | ||
| 14-Day ATR ($) | 0.000865 | ||
| 20-Day SMA ($) | 16 | ||
| 12-1 Month Momentum % | 60 | ||
| 52-Week Range ($) | 10 - 16 | ||
| Shares Outstanding (Mil) | 206.52 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
VitaSpring Biomedical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
VitaSpring Biomedical Co Ltd Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
VitaSpring Biomedical Co Ltd Frequently Asked Questions
What is VitaSpring Biomedical Co Ltd(VSBC)'s stock price today?
The current price of VSBC is $16.00. The 52 week high of VSBC is $16.00 and 52 week low is $10.00.
When is next earnings date of VitaSpring Biomedical Co Ltd(VSBC)?
The next earnings date of VitaSpring Biomedical Co Ltd(VSBC) is .
Does VitaSpring Biomedical Co Ltd(VSBC) pay dividends? If so, how much?
VitaSpring Biomedical Co Ltd(VSBC) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers